Utility of antidiabetes medications in chronic kidney disease: A review

Emily Knezevich, Annette Kueser

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


There is a large body of evidence describing the utility of antidiabetes agents in people with chronic kidney disease (CKD). Clinical decisions should take into account the pharmacokinetic variability and potential adverse events seen when these agents are used in renally impaired patients. In this article, the authors review the literature and summarise which antidiabetes agents are safe, with dose reductions if necessary, in people with CKD.

Original languageEnglish (US)
Pages (from-to)358-363
Number of pages6
JournalJournal of Diabetes Nursing
Issue number10
StatePublished - 2016

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing


Dive into the research topics of 'Utility of antidiabetes medications in chronic kidney disease: A review'. Together they form a unique fingerprint.

Cite this